Przegląd Menopauzalny

Full text

1/2026 vol. 25
Original paper

Association between the triglyceride-glucose index and its correlation indices and stress urinary incontinence in American adult women: a population-based cross-sectional study

  1. Department of Obstetrics and Gynecology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China

Menopause Rev 2026; 25(1): 1-9

Data publikacji online: 2026/05/06
Article file
00987 Association between (2).pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Stress urinary incontinence (SUI), characterized by the involuntary leakage of urine during physical exertion or increased abdominal pressure, is a prevalent and burdensome condition affecting more than 30% of adult women in the United States [1, 2]. It is characterized by involuntary urine leakage, particularly during physical exertion or activities that increase abdominal pressure, such as sneezing or exercising [3]. Stress urinary incontinence is associated with substantial costs and the implications of SUI extend beyond physical discomfort [4]. It negatively affects the quality of life of those affected, leading to emotional distress, social isolation, and decreased participation in daily activities [5, 6]. Advanced age, childbirth experiences (including vaginal deliveries), and the menopausal transition are well-established risk factors for the development of SUI. The aetiology of SUI is multifactorial, encompassing not only these factors but also genetic predisposition, obesity, chronic conditions that increase intra-abdominal pressure (e.g., chronic cough, constipation), and connective tissue disorders [710].

Emerging evidence suggests that metabolic dysregulation may play a role in the pathophysiology of pelvic floor disorders, including SUI. Conditions such as obesity, diabetes, and metabolic syndrome have been implicated in altering the structure and function of pelvic floor support mechanisms [11, 12]. The triglyceride-glucose (TyG) index – a validated surrogate of insulin resistance calculated from fasting triglycerides and glucose – has demonstrated significant associations with cardiometabolic disorders including cardiovascular disease, chronic kidney disease, and non-alcoholic fatty liver disease [1315]. To enhance clinical utility, adiposity-integrated derivatives (TyG-body mass index (BMI), TyG-waist circumference (WC), and TyG-waist-to-height ratio (WHtR)) have been developed, showing improved predictive capacity for metabolic outcomes compared to the original TyG index [1620]. Despite extensive research on TyG indices in cardiometabolic contexts, critical knowledge gaps persist regarding urological applications. Furthermore, evidence linking modifiable metabolic markers to SUI remains limited in nationally representative cohorts.

Therefore, this study aimed to investigate the association between the TyG index and its adiposity-combined indices (TyG-BMI, TyG-WC, TyG-WHtR) and the prevalence of SUI among U.S. adult women. To address these gaps, this cross-sectional study leveraged the National Health and Nutrition Examination Survey (NHANES 2001–2023) to conduct comprehensive assessment of TyG and its clinically accessible derivatives (TyG-BMI, TyG-WC, TyG-WHtR) in relation to SUI among U.S. women.

Material and methods

Study design and data source

The data for this cross-sectional study were obtained from the NHANES, which is designed to evaluate the health and nutritional status of the general U.S. population. The National Health and Nutrition Examination Survey gathers extensive data on diverse areas, such as demographics, financial status, and public health. As shown in the flowchart, we initially included 109,590 people across ten cycles from 2001 to 2023. We excluded men, individuals under 20 years old, individuals with missing TyG and related indicators, and individuals with missing SUI data. Ultimately, the analysis included 9,184 individuals as shown in Figure 1. Reporting of this study followed the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement [21]. The datasets generated and analysed in the current study are available at the NHANES website: https://wwwn.cdc.gov/nchs/nhanes/Default.aspx.

Figure 1

Research sample screening flow chart

/f/fulltexts/PM/57982/MR-25-57982-g001_min.jpg

Assessment of stress urinary incontinence

Stress urinary incontinence I was assessed via self-reported data from the Kidney Conditions – Urology file. Participants were identified as having SUI if they responded affirmatively to item KIQ042: “Do you leak urine during physical activities (e.g., coughing, lifting, or exercise)?” [22].

Calculation of triglyceride-glucose correlation indices

The triglyceride-glucose index and its derivatives were calculated as follows [23]:

  • TyG = ln[fasting triglycerides (mg/dl) × fasting glucose (mg/dl)/2],

  • TyG-BMI = TyG × BMI,

  • TyG-WC = TyG × WC,

  • TyG-WHtR = TyG × WHtR.

Assessment of covariates

The research assessed covariates including: age; ethnicity; poverty income ratio (poor [< 1.0], nearly poor [1.0–1.9], middle income [2.0–3.9], high income [≥ 4.0]); education level (below high school, high school, above high school); smoking status (never, former, current); alcohol use (never, former, current); physical activity; vaginal deliveries; hypertension (defined as systolic/diastolic blood pressure ≥ 140/90 mm Hg, current antihypertensive medication use, clinician-diagnosed hypertension, or self-reported prescription antihypertensive use regardless of current blood pressure levels), diabetes mellitus (diagnosed by clinician assessment, HbA1c ≥ 6.5%, fasting glucose ≥ 7.0 mmol/l, random glucose ≥ 11.1 mmol/l, 2-hour oral glucose tolerance test glucose ≥ 11.1 mmol/l, or current glucose-lowering medication/insulin therapy); and menopausal status.

Statistical analysis

Categorical data are presented as frequency (%), continuous variables as mean ± standard deviation or median. Adult women were grouped by SUI status, and group differences were compared using ANOVA, Kruskal-Wallis, or χ2 tests. Triglyceride-glucose and related indices (TyG-BMI, TyG-WC, TyG-WHtR) were analysed as continuous variables and tertiles (T1–T3). Multivariate logistic regression assessed their association with SUI. Triglyceride-glucose-BMI and TyG-WC were scaled per 100 units due to large magnitudes, preserving data trends. Results are reported as odds ratio (OR) (95% CI). Three adjustment models were constructed. Nonlinear associations were examined using smooth curve fitting.

Subgroup analysis was performed according to age (< 60, ≥ 60), ethnicity, education level, physical activity, smoking status, alcohol status, hypertension, diabetes, vaginal deliveries (< 3, ≥ 3) and menopause status. Sensitivity analyses were conducted to verify robustness. Covariates with missing values < 1% were retained without imputation. For categorical variables with > 1% missing data, missing values were categorized as a separate “Missing” group to preserve sample size and minimize bias. All statistical analyses were performed using EmpowerStats software (X&Y Solutions, Inc., Boston, MA, USA). The two-sided p-values less than 0.05 were considered statistically significant.

Results

Baseline characteristics

Table 1 describes the study population (n = 9,184), which included 3,836 women (41.76%) who reported SUI. Compared to women without SUI, those with SUI were significantly older and had higher mean levels of all TyG indices (TyG, TyG-BMI, TyG-WC, and TyG-WHtR; all p < 0.001). Significant differences were also observed in ethnicity, education level, smoking and alcohol status, physical activity, hypertension, diabetes, and menopause status (higher prevalence in SUI). Vaginal deliveries were also more frequent in the SUI group (≥ 3). Only the poverty income ratio showed no significant difference (p = 0.079).

Table 1

Characteristics of the study population

ParametersTotal, N= 9184 (%)Stress urinary incontinencep-value
No, n = 5348 (%)Yes, n = 3836 (%)
Age, mean (SD) [years]49.58 (17.76)46.96 (18.41)53.23 (16.13)< 0.001
TyG, mean (SD) [mmol/l]8.55 (0.66)8.46 (0.65)8.67 (0.66)< 0.001
TyG-BMI, mean (SD) [kg/m2]254.58 (72.45)244.08(69.93)269.23 (73.36)< 0.001
TyG-WC, mean (SD) [cm]840.36 (177.76)811.72 (173.41)880.29 (176.05)< 0.001
TyG-WHtR, mean (SD)5.24 (1.12)5.05 (1.09)5.50 (1.11)< 0.001
Ethnicity3951 (43.02)2105 (39.36)1846 (48.12)< 0.001
  Non-Hispanic White3951 (43.02)2105 (39.36)1846 (48.12)
  Non-Hispanic Black1941 (21.13)1362 (25.47)579 (15.09)
  Mexican American1445 (15.73)766 (14.32)679 (17.70)
  Other1847 (20.11)1115 (20.85)732 (19.08)
Poverty income ratio
  Poor1815 (19.76)1075 (20.10)740 (19.29)0.079
  Nearly poor2224 (24.22)1238 (23.15)986 (25.70)
  Middle income2268 (24.70)1332 (24.91)936 (24.40)
  High income2084 (22.69)1240 (23.19)844 (22.00)
  Missing793 (8.63)463 (8.66)330 (8.60)
Education level
  Below high school883 (9.61)446 (8.34)437 (11.39)< 0.001
  High school3266 (35.56)1862 (34.82)1404 (36.60)
  Above high school5028 (54.75)3037 (56.79)1991 (51.90)
  Missing7 (0.08)3 (0.06)4 (0.10)
Smoking status
  Never5813 (63.29)3527 (65.95)2286 (59.59)< 0.001
  Former1813 (19.74)960 (17.95)853 (22.24)
  Current1551 (16.89)857 (16.02)694 (18.09)
  Missing7 (0.08)4 (0.07)3 (0.08)

[i] TyG – triglyceride level, TyG-BMI – triglyceride - body mass index, TyG-WC – triglyceride - waist circumference, TyG-WHtR – triglyceride - waist-to-height ratio Among the 9184 patients, the number of missing values for the covariates were 793 (8.63%) for poverty income ratio; 7 (0.08%) for education level; 7 (0.08%) for smoking status; 401 (4.38%) for alcohol status; 2720 (29.62%) for physical activity; 369 (4.02%) for diabetes mellitus; 3586 (39.05%) for vaginal deliveries; 15 (0.16%) for menopause status.

Association between triglyceride-glucose indices and stress urinary incontinence

Table 2 shows significant positive correlations between all TyG indices (TyG, TyG-BMI, TyG-WC, and TyG-WHtR) and SUI in progressively adjusted models. Strong dose-response relationships were evident, with significantly increasing odds of SUI observed across tertiles for each index (all p-value for trend < 0.001). Participants in the highest tertile (T3) exhibited a substantially elevated SUI risk compared to those in the lowest tertile (T1) in all models. These significant positive associations persisted after adjusting for sociodemographic, behavioural, and clinical confounders in the fully adjusted model (Model 3). Among all indices examined, TyG-BMI demonstrated the strongest association with SUI risk.

Table 2

Relationship between triglyceride-glucose index and its correlation indices and stress urinary incontinence

ParametersOR (95% CI) p-value
Model 1Model 2Model 3
TyG [mmol/l]
  Continuous1.62 (1.52, 1.73) < 0.0011.34 (1.25, 1.43) < 0.0011.27 (1.17, 1.37) < 0.001
  T11.01.01.0
  T21.47 (1.33, 1.64) < 0.0011.21 (1.08, 1.35) 0.00071.15 (1.03, 1.29) 0.0167
  T32.16 (1.95, 2.39) < 0.0011.59 (1.42, 1.78) < 0.0011.46 (1.29, 1.66) < 0.001
  p-value for trend1.47 (1.39, 1.55) < 0.0011.26 (1.19, 1.34) < 0.0011.21 (1.14, 1.29) < 0.001
TyG-BMI [kg/m2]
  Continuous1.63 (1.53, 1.73) < 0.0011.66 (1.56, 1.77) < 0.0011.69 (1.58, 1.82) < 0.001
  T11.01.01.0
  T21.76 (1.58, 1.95) < 0.0011.63 (1.46, 1.82) < 0.0011.61 (1.44, 1.81) < 0.001
  T32.44 (2.20, 2.71) < 0.0012.47 (2.21, 2.76) < 0.0012.50 (2.21, 2.82) < 0.001
  p-value for trend1.56 (1.48, 1.64) < 0.0011.57 (1.48, 1.66) < 0.0011.58 (1.49, 1.68) < 0.001
TyG-WC [cm]
  Continuous1.25 (1.22, 1.28) < 0.0011.22 (1.19, 1.26) < 0.0011.24 (1.20, 1.28) < 0.001
  T11.01.01.0
  T21.79 (1.61, 1.99) < 0.0011.60 (1.44, 1.79) < 0.0011.58 (1.41, 1.77) < 0.001
  T32.48 (2.23, 2.75) < 0.0012.25 (2.02, 2.52) < 0.0012.29 (2.02, 2.59) < 0.001
  p-value for trend1.57 (1.49, 1.65) < 0.0011.50 (1.42, 1.58) < 0.0011.51 (1.42, 1.61) < 0.001
TyG-WHtR
  Continuous1.45 (1.40, 1.51) < 0.0011.39 (1.33, 1.44) < 0.0011.42 (1.35, 1.49) < 0.001
  T11.01.01.0
  T21.77 (1.59, 1.97) < 0.0011.58 (1.41, 1.77) < 0.0011.57 (1.40, 1.76) < 0.001
  T32.66 (2.40, 2.96) < 0.0012.33 (2.08, 2.60) < 0.0012.39 (2.10, 2.71) < 0.001
  p-value for trend1.63 (1.55, 1.72) < 0.0011.52 (1.44, 1.61) < 0.0011.54 (1.45, 1.65) < 0.001

[i] TyG – triglyceride level, BMI – body mass index per 100-unit increase, WC – waist circumference per 100-unit increase, WHtR – waist-to-height ratio

Model 1 – no adjustments made

Model 2 – adjusted for age, ethnicity, poverty income ratio, education level

Model 3 – adjusted for age, ethnicity, poverty income ratio, education level, smoking status, alcohol status, physical activity, hypertension, diabetes mellitus, vaginal deliveries, menopause status

Nonlinear relationships

The results of the smooth curve fitting are shown in Figure 2, TyG and its correlation indices had a significant non-linear relationship with SUI (p < 0.001).

Figure 2

The smooth curve fitting

TyG index and its correlation indexes were non-linear correlated with stress urinary incontinence. The solid red line and Shadows indicate predicted values and 95% confidence intervals.

/f/fulltexts/PM/57982/MR-25-57982-g002_min.jpg

Subgroup analyses

Figure 3 illustrates that the subgroup analyses consistently demonstrate a robust relationship between the TyG and its correlation indices and SUI across various demographic and clinical groups. This consistency underscores the reliability of these associations.

Figure 3

Subgroup analysis. The relationship between TyG (A), TyG-BMI (B), TyG-WC (C), TyG-WHtR (D) and stress urinary incontinence in different groups

/f/fulltexts/PM/57982/MR-25-57982-g003_min.jpg

Notably, significant interaction effects were observed in several analyses. Specifically, for the TyG index, age yielded a strong interaction (p = 0.01), indicating a greater association with SUI among individuals under 60. Ethnicity influenced the relationship for TyG-BMI (p = 0.01) and TyG-WHtR (p = 0.01), highlighting variability across different racial groups. Additionally, the interaction of diabetes mellitus with TyG-BMI (p = 0.04) and TyG-WHtR (p = 0.04) suggests that individuals with diabetes exhibit a stronger link to SUI. Vaginal deliveries also influenced the TyG-WHtR relationship (p = 0.02). Collectively, these findings affirm the strength and consistency of triglyceride-related indices regarding SUI while acknowledging the complexities introduced by specific subgroup characteristics.

Discussion

This study investigated the association between TyG indices and SUI among American adult women, utilizing data from the NHANES spanning from 2001 to 2023. Our findings revealed a significant prevalence of SUI (41.77%) in the study population, with higher TyG indices correlating with increased odds of SUI. Specifically, the highest tertiles of TyG, TyG-BMI, TyG-WC, and TyG-WHtR were associated with elevated risks of SUI, indicating that these indices may serve as independent risk factors and potential screening tools for SUI in women. The study highlights the importance of metabolic health in understanding pelvic floor disorders and suggests that TyG-derived indices could be valuable in clinical settings. Critically, our results establish a clear, dose-dependent positive relationship: elevated levels of the selected indices – TyG, TyG-BMI, TyG-WC, and particularly TyG-WHtR – are consistently and independently associated with a higher prevalence of SUI.

Recent studies have begun exploring metabolic dysregulation in SUI pathogenesis. Huang et al. [24] conducted a parallel NHANES-based study (2005–2018) focusing exclusively on postmenopausal women. They reported that TyG-BMI and TyG-WHtR were significantly associated with SUI risk, with TyG-BMI demonstrating the highest diagnostic accuracy (area under the curve (AUC) = 0.582), while baseline TyG showed no significant correlation after adjustment – a finding contrasting with our results. Concurrently, Pu et al. [25] utilizing NHANES data (2011–2018) encompassing a broader adult female cohort (n = 4,459), established a positive association between the TyG index and SUI prevalence. Li et al. [22] further examined TyG-BMI across all UI subtypes (SUI/UUI/MUI) in a general adult cohort (2001–2018), confirming TyG-BMI as an independent risk factor for SUI (OR = 2.36 for Q4 vs. Q1). Our study significantly expands the scope by incorporating multiple adiposity-combined indices (TyG-BMI, TyG-WC, TyG-WHtR) within a substantially larger cohort (n = 9,184). Our work advances the field by: (1) demonstrating the pronounced superiority of adiposity-combined indices (particularly TyG-BMI, OR = 2.50 for T3 vs. T1) over the baseline TyG index in predicting SUI risk across the general female population, (2) establishing TyG-WHtR’s enhanced diagnostic utility (AUC = 0.619) relative to other TyG measures in this context, and (3) uncovering significant metabolic-subgroup interactions (e.g., age, ethnicity, diabetes status, vaginal delivery history) that refine SUI risk stratification beyond what previous studies, including Pu et al. [25], have reported.

This association may be underpinned by the metabolic dysregulation reflected in elevated TyG indices, which can promote chronic inflammation and oxidative stress, potentially compromising the integrity and function of pelvic floor supportive tissues. Interventions targeting metabolic health, such as dietary modification and physical exercise, have been shown to ameliorate similar inflammatory and metabolic disturbances in other conditions, suggesting a plausible pathway for intervention in SUI [26, 27]. Triglyceride-glucose indices serve as indicators of insulin resistance, a condition that can contribute to pelvic floor dysfunction through mechanisms such as neuro-mitochondrial impairment and chronic inflammation. Elevated insulin levels, characteristic of insulin resistance, can disrupt the phosphoinositide 3-kinase/protein kinase B signalling cascade, potentially impairing mitochondrial function in peripheral neurons that control bladder function. This disruption could lead to oxidative stress and apoptosis of urethral sphincter myocytes, which diminishes their contractile efficacy [28, 29].

Adipose tissue, particularly visceral fat, produces pro-inflammatory cytokines such as tumor necrosis factor α and interleukin-6, which play a detrimental role in degrading pelvic collagen and weakening supportive structures through the activation of matrix metalloproteinases [30]. Concurrently, central obesity, as measured by BMI, WC, and WHtR, may exacerbate these effects. Research indicates that increased intra-abdominal pressure can impose chronic biomechanical strain on the pelvic floor, leading to stretching of connective tissues and potential compression of pudendal nerves, further complicating pelvic function [29, 31]. Some murine studies also suggest that there may be an association between elevated TyG-BMI and urethral sphincter atrophy, as well as a decrease in pelvic muscle electromyographic activity [31].

Furthermore, the weakening of the association between TyG indices and SUI in postmenopausal women suggests a complex interplay between hormonal factors and metabolic dysregulation affecting bladder control. The protective role of oestrogen in maintaining pelvic floor function could explain this phenomenon [24]. Some studies suggest that hormone replacement therapy is associated with improvements in pelvic support and muscle function [32].

Strengths and limitations

This study has several notable strengths. First, it utilizes a large, nationally representative sample from NHANES (n = 9,184), which provides high statistical power and enhances the generalizability of our findings to the non-institutionalized U.S. adult female population. Second, we employed a standardized, widely used questionnaire item to define SUI, ensuring consistency in outcome assessment. Third, beyond the baseline TyG index, we comprehensively evaluated multiple, clinically accessible adiposity-combined indices (TyG-BMI, TyG-WC, TyG-WHtR), which offered improved predictive utility for SUI risk and aligns with the multifactorial nature of metabolic health. Finally, our analyses were rigorously adjusted for a wide array of potential confounders, including sociodemographic, behavioural, and clinical factors, and we further explored dose-response relationships, non-linearity, and effect modification through subgroup analyses, thereby providing a nuanced understanding of the associations. However, there are limitations to consider. First, its cross-sectional design precludes the inference of causality between TyG indices and SUI. Second, SUI was defined by a single self-reported questionnaire item, which may lead to underreporting or misclassification. Third, the findings are derived from a U.S. population and may not be directly generalizable to other ethnic or healthcare settings.

Clinical relevance

The findings of this population-based study carry several clinical implications. First, the TyG index and its derivatives, particularly TyG-WHtR, are calculated from routine, low-cost measurements (fasting blood tests, waist circumference, height, and weight). This makes them potentially accessible and practical tools for clinicians to identify women at higher risk of SUI within general or at risk populations (e.g., those with obesity or metabolic syndrome). Second, the strong, independent associations observed, especially for the adiposity-combined indices, reinforce the importance of assessing and addressing metabolic health – including insulin resistance and central obesity – as part of a holistic approach to pelvic floor health. While these indices are not diagnostic for SUI, they could help in risk stratification and prompt earlier lifestyle counselling or more targeted clinical evaluation for urinary symptoms.

Future recommendations

Based on these findings, future research should: employ longitudinal designs to establish the temporal relationship and potential causality between TyG indices and incident SUI, investigate whether interventions that improve metabolic health and reduce TyG indices – such as the lifestyle modification programs shown to be effective in other conditions – could also prevent or alleviate SUI symptoms.

Conclusions

In this nationally representative cross-sectional study of U.S. women, higher levels of the TyG index and its adiposity-combined indices (TyG-BMI, TyG-WC, and TyG-WHtR) demonstrated significant, dose-dependent positive associations with the prevalence of SUI. Among these, TyG-WHtR showed the strongest association.

Disclosures

  1. Institutional review board statement: The protocols of the NHANES were approved by the Institutional Review Board of the National Center for Health Statistics, CDC (https://www.cdc.gov/nchs/nhanes/about/erb.html). Written informed consent was obtained from all participants in the NHANES. All procedures were conducted in accordance with the ethical standards of the Declaration of Helsinki.

  2. Assistance with the article: None.

  3. Financial support and sponsorship: This work was supported by the 2024 Zhejiang Provincial Traditional Chinese Medicine Science and Technology Plan (Project No. 2024ZL1252).

  4. Conflicts of interest: None.

References

1 

Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol 2014; 123: 141-148.

2 

Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. Bju Int 2009; 103: 4-11.

3 

Zilberlicht A, Karmakar D, Dwyer P, Chan G, Schierlitz L. Counseling for stress urinary incontinence in the era of adverse publicity around mesh usage: results from a large-sample global survey. Int J Gynecol Obstet 2022; 160: 579-587.

4 

Subak LL, Brubaker L, Chai TC, Creasman JM, Diokno AC, Goode PS, et al. High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstet Gynecol 2008; 111: 899-907.

5 

Cho SY, Jeong SJ, Yeo JK, Kim S, Jeong J, Choi JB, et al. Nationwide database of surgical treatment pattern for patients with stress urinary incontinence in Korea. Int Neurourol J 2014; 18: 91.

6 

Chow PM, Chuang YC, Hsu K, Shen YC, Liu SP. Impact of female stress urinary incontinence on quality of life, mental health, work limitation, and healthcare seeking in China, Taiwan, and South Korea (LUTS Asia): results from a cross-sectional, population-based study. Int J Womens Health 2022; 14: 1871-1880.

7 

Şensoy N, Doğan N, Ozek B, Karaaslan L. Urinary incontinence in women: prevalence rates, risk factors and impact on quality of life. Pak J Med Sci 2013; 29: 818-822.

8 

Handa VL, Blomquist JL, Knoepp LR, Hoskey KA, McDermott KC, Muñoz Á. Pelvic floor disorders 5–10 years after vaginal or cesarean childbirth. Obstet Gynecol 2011; 118: 777-784.

9 

  Wu JM. Stress incontinence in women. New Engl J Med 2021; 384: 2428-2436.

10 

Barbosa AMP, Marini G, Pículo F, Rudge CVC, Calderon IDMP, Rudge MVC. Prevalence of urinary incontinence and pelvic floor muscle dysfunction in primiparae two years after cesarean section: cross-sectional study. Sao Paulo Med J 2013; 131: 95-99.

11 

Ströher R, Sartori M, Takano CC, de Araújo MP, Girão M. Metabolic syndrome in women with and without stress urinary incontinence. Int Urogynecol J 2020; 31: 173-179.

12 

Huang H, Han X, Liu Q, Xue J, Yu Z, Miao S. Associations between metabolic syndrome and female stress urinary incontinence: a meta-analysis. Int Urogynecol J 2022; 33: 2073-2079.

13 

Cui C, Liu L, Zhang T, Fang L, Mo Z, Qi Y, et al: Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol 2023; 22: 325.

14 

Jin Z, Zhang K. Association between triglyceride-glucose index and AKI in ICU patients based on MIMICIV database: a cross-sectional study. Renal Failure 2023; 45: 2238830.

15 

Lei L, Liang H, Qu Y, Zhong Q, Zhang Q, Dai L, et al. Association between triglyceride-glucose index and worsening renal function in the elderly. Front Nutr 2022; 9: 951564.

16 

Song S, Son DH, Baik SJ, Cho W, Lee YJ. Triglyceride glucose-waist circumference (TyG-WC) is a reliable marker to predict non-alcoholic fatty liver disease. Biomedicines 2022; 10: 2251.

17 

Chen J, Chen A, Yang S, Zhang F, Jiang H, Liu J, et al. Association of triglyceride glucose and obesity indices with chronic obstructive pulmonary disease in US adults: data from 2013 to 2018 NHANES. BMC Pulm Med 2025; 25: 268.

18 

Niu S, Jiang C, Miao X, Zhang Y, Li Z, Wang T. Association of triglyceride-glucose related indices with colorectal cancer risk among the US population: a cross-sectional study. BMC Cancer 2025; 25: 1186.

19 

Gong R, Ding Y, Yang K, Meng X, Sun X. Association between various insulin resistance surrogates and gallstone disease based on national health and nutrition examination survey. Sci Rep 2025; 15: 25877.

20 

Wang Y, Wang H, Cheng B, Xia J. Associations between triglyceride glucose index-related obesity indices and anxiety: insights from the National Health and Nutrition Examination Survey 2007–2012. J Affect Disorders 2025; 382: 443-452.

21 

Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Plos Med 2007; 4: e296.

22 

Li J, Xie R, Tian H, Wang D, Mo M, Yang J, et al. Association between triglyceride glucose body mass index and urinary incontinence: a cross-sectional study from the National Health and Nutrition Examination Survey (NHANES) 2001 to 2018. Lipid Health Dis 2024; 23: 304.

23 

Yan Z, Chang X, Liu Z, Liu R, Du X. The association of obesity and lipid-related indicators with all-cause and cardiovascular mortality risks in patients with diabetes or prediabetes: a cross-sectional study based on machine learning algorithms. Front Endocrinol 2025; 16: 1492082.

24 

Huang X, Hu W, Li L. Association between triglyceride-glucose index and its correlation indexes and stress urinary incontinence in postmenopausal women: evidence from NHANES 2005–2018. Lipid Health Dis 2024; 23: 419.

25 

Pu Y, Feng Y, Zhao W. The association between triglyceride glucose index and stress urinary incontinence in adult American women: a population-based study. Neurourol Urodynam 2024; 43: 2030-2038.

26 

Ismail A, Saad AE, Draz RS. Effect of low-calorie diet on psoriasis severity index, triglycerides, liver enzymes, and quality of life in psoriatic patients with non-alcoholic fatty liver disease. Reumatologia 2023; 61: 116-122.

27 

Ismail A, Morsy MM. Effect of Baduanjin exercise on lipid profile, blood pressure, and thyroid-stimulating hormone in elderly with subclinical hypothyroidism and mild cognitive impairment: a randomized-controlled trial in women. Geriatr Nurs 2025; 64: 103434.

28 

Huang D, Ma R, Zhong X, Jiang Y, Lu J, Li Y, et al. Positive association between different triglyceride glucose index-related indicators and psoriasis: evidence from NHANES. Front Immunol 2023; 14: 1325557.

29 

Zhou Y, Xue F. Exploring the association between triglyceride-glucose indices and their derivatives with obstructive sleep apnea: insights from the national health and nutrition examination survey. Nat Sci Sleep 2025; 17: 143-155.

30 

Ma H, Zhang W, Zhao Z, Jin S, Li L, Zong R, et al. Association between triglyceride-glucose related indices and at-risk NASH in U.S. adults with NAFLD: results from NHANES 2017–2020. Front Endocrinol 2025; 16: 16:1604991.

31 

Akl NSA, Khalifa O, Habibullah M, Arredouani A. Salivary α-amylase activity is associated with cardiometabolic and inflammatory biomarkers in overweight/obese, non-diabetic Qatari women. Front Endocrinol 2024; 15: 1348853.

32 

Chiang CH, Jiang YH, Kuo HC. Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding. Sci Rep 2021; 11.

Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees